JP2023552468A5 - - Google Patents

Info

Publication number
JP2023552468A5
JP2023552468A5 JP2023534907A JP2023534907A JP2023552468A5 JP 2023552468 A5 JP2023552468 A5 JP 2023552468A5 JP 2023534907 A JP2023534907 A JP 2023534907A JP 2023534907 A JP2023534907 A JP 2023534907A JP 2023552468 A5 JP2023552468 A5 JP 2023552468A5
Authority
JP
Japan
Application number
JP2023534907A
Other languages
Japanese (ja)
Other versions
JPWO2022122689A5 (https=
JP2023552468A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/084488 external-priority patent/WO2022122689A1/en
Publication of JP2023552468A publication Critical patent/JP2023552468A/ja
Publication of JP2023552468A5 publication Critical patent/JP2023552468A5/ja
Publication of JPWO2022122689A5 publication Critical patent/JPWO2022122689A5/ja
Pending legal-status Critical Current

Links

JP2023534907A 2020-12-09 2021-12-07 Rnaの製造 Pending JP2023552468A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063123465P 2020-12-09 2020-12-09
US63/123,465 2020-12-09
US202063132473P 2020-12-30 2020-12-30
US63/132,473 2020-12-30
PCT/EP2021/084488 WO2022122689A1 (en) 2020-12-09 2021-12-07 Rna manufacturing

Publications (3)

Publication Number Publication Date
JP2023552468A JP2023552468A (ja) 2023-12-15
JP2023552468A5 true JP2023552468A5 (https=) 2024-12-16
JPWO2022122689A5 JPWO2022122689A5 (https=) 2024-12-16

Family

ID=79287682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534907A Pending JP2023552468A (ja) 2020-12-09 2021-12-07 Rnaの製造

Country Status (10)

Country Link
US (1) US20240110214A1 (https=)
EP (1) EP4259161A1 (https=)
JP (1) JP2023552468A (https=)
KR (1) KR20230129432A (https=)
AU (1) AU2021395736A1 (https=)
CA (1) CA3201552A1 (https=)
IL (1) IL303457A (https=)
MX (1) MX2023006126A (https=)
TW (1) TW202237844A (https=)
WO (1) WO2022122689A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
TW202306573A (zh) * 2021-05-26 2023-02-16 比利時商eTheRNA免疫治療公司 減少雙股rna副產物形成的方法
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
JP2024534120A (ja) 2021-08-24 2024-09-18 ビオンテック・ソシエタス・エウロパエア インビトロ転写技術
CN121263517A (zh) * 2023-02-01 2026-01-02 美国金斯瑞公司 体外转录方法和用于其中的化合物
EP4705499A1 (en) * 2023-05-05 2026-03-11 TriLink BioTechnologies, LLC In vitro transcription method
WO2025170909A1 (en) * 2024-02-05 2025-08-14 The Broad Institute, Inc. Nucleic acids with region-specific modifications and methods of making the same
WO2025223684A1 (en) * 2024-04-23 2025-10-30 BioNTech SE Methods and compositions for stimulating immune response

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7839594A (en) 1993-09-20 1995-04-10 Regents Of The University Of Colorado, The Strategy for the production of rna from immobilized templates
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
EP2049665A2 (en) 2006-07-28 2009-04-22 Applera Corporation Dinucleotide mrna cap analogs
WO2008157688A2 (en) 2007-06-19 2008-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
DE102008061522A1 (de) 2008-12-10 2010-06-17 Biontech Ag Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
RU2013120302A (ru) 2010-10-01 2014-11-20 Модерна Терапьютикс, Инк. Сконструированные нуклеиновые кислоты и способы их применения
WO2013059475A1 (en) 2011-10-18 2013-04-25 Life Technologies Corporation Alkynyl-derivatized cap analogs, preparation and uses thereof
US10837039B2 (en) 2014-06-10 2020-11-17 Curevac Real Estate Gmbh Methods and means for enhancing RNA production
WO2016005004A1 (en) 2014-07-11 2016-01-14 Biontech Rna Pharmaceuticals Gmbh Stabilization of poly(a) sequence encoding dna sequences
ES2964690T3 (es) 2015-09-21 2024-04-09 Trilink Biotechnologies Llc Método para sintetizar ARN con caperuza 5'
WO2017059902A1 (en) 2015-10-07 2017-04-13 Biontech Rna Pharmaceuticals Gmbh 3' utr sequences for stabilization of rna
EP3882343A3 (en) 2016-01-13 2021-12-08 New England Biolabs, Inc. Thermostable variants of t7 rna polymerase
US10337051B2 (en) * 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
EP4599847A3 (en) 2016-10-25 2025-11-12 Trustees of Dartmouth College Prefusion coronavirus spike proteins and their use

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023552468A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)